Starts:  May 5, 2018 8:00 AM (ET)
Ends:  May 8, 2018 12:00 PM (ET)

GEST 2018 U.S. is a comprehensive continuing medical education program dedicated to embolization and oncologic interventions.

 Educational Objectives:

  • Compare the relative advantages and timing of different endoleak therapies
  • Assess current data for evaluation of upper GI bleeding treated by embolization
  • Determine interventional oncologic therapy decisions based on the latest evidence, established patient care standards and multidisciplinary¬†¬† approaches.
  • Describe the latest imaging technique that may help in performing intra arterial treatment of liver cancer.
  • Describe the latest options and differences in function, characteristics, and potential outcomes of various devices for embolization.
  • Discuss the new therapeutic options using embolization in hemorrhoid-related bleeding, and chronic shoulder pain.
  • Discuss basic and variant prostate artery anatomy and techniques to identify critical vasculature during therapy.
  • Assess patient symptoms and treatment options for symptomatic benign prostatic hyperplasia, including drug treatment, surgery, and embolization.
  • Explain the indications and results of uterine fibroid and adenomyosis embolization.
  • Summarize the advantages, limitations, technical aspects, and endpoints of various tools and approaches to visceral aneurysm treatment.

Target Audience Description:

GEST 2018 U.S. will be of value to interventional radiologists, oncologists, diagnostic radiologists, nurses, radiology technologists, physician assistants, and other healthcare professionals interested in the field of embolization.